Sign in
Not yet taking people in United StatesPhase 1/2

Ear nerve stimulation for people recently injured with spinal cord injury

Tests safety of a small ear device alongside walking therapy after recent spinal cord injury.

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham, United StatesSee the site
Trial code
Registry title
Pilot Testing of Vagus Nerve Stimulation for Early Spinal Cord Injury Recovery
Status
Not yet recruiting
Phase
Phase 1/2
People taking part
50 people, planned
Started
1 Nov 2026
Expected to end
15 Dec 2027
Type of study
Interventional
Treatments tested
  • Transauricular vagus nerve stimulation
Record updated
5 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a recent spinal cord injury who are in their first inpatient rehabilitation stay. It tests an ear-worn nerve stimulation device (taVNS).

Age
18 Years to 89 Years
Sex
All sexes can join.
Disease stage
Spinal cord injury from an accident or from another cause, during the first inpatient rehabilitation. Any AIS severity level (A, B, C, D) can join. For part 2, people must have finished part 1 and get intensive walking training as part of their care plan, and the study doctor must approve.

Main reasons for not taking part

  • Pregnancy
  • An implanted medical device, such as a pacemaker or cochlear implant, a brain shunt, or metal implants inside the skull
  • Epilepsy, Parkinson's Disease or Multiple Sclerosis
  • A documented irregular heartbeat (arrhythmia)
  • Skin irritation or damage on the ear where the electrode goes

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Phase 1 Age 18 years older SCI (traumatic or non traumatic) undergoing initial inpatient rehabilitation for the SCI Any AIS severity level (A, B, C, D)
  • Phase 2 Completed phase I Participant willing to complete phase II Study physician approves participation in phase II Receives intensive gait training as a part of the care plan

Who cannot take part

  • Phase 1 Age >89 years Pregnant Implanted medical device (e.g. pacemaker, cochlear implant) epilepsy Parkinson's Disease Multiple Sclerosis cerebral shunts documented arrhythmia Ear skin irritation or damage at the electrode contact location intracranial metal implants
  • Phase 2 no exclusion criteria for those who meet inclusion criteria

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 89 years old?

Where in United States

  • University of Alabama at BirminghamBirmingham, United StatesContact: Rachel E Cowan, PhDNot yet recruiting

About the trial

What the trial wants to find out

This study looks at a treatment called transcutaneous auricular vagus nerve stimulation, or taVNS. taVNS uses a small device worn on the ear to gently stimulate a nerve. Researchers want to find out if this treatment is safe and well-tolerated for people who recently had a spinal cord injury (SCI).

Read full original descriptionShow less

This study will also help researchers learn whether taVNS can be safely added to standard mobility therapy, and whether it might help improve mobility.

This study has two main goals:

1. To find out whether taVNS is safe and comfortable for people with a recent spinal cord injury. 2. To get information on whether taVNS may help improve mobility when compared to people who completed rehabilitation before this study started.

This study has two parts.

In the first part, participants will wear the taVNS device once for a short period of time. During this part investigators will measure how participant's heart rate and blood pressure may change before, during, and after the stimulation. Investigators will also ask about how the stimulation made participants feel.

In the second part, participants will wear the taVNS device for a short time right before a mobility therapy session. During this part investigators will measure how participants heart rate and blood pressure may change before, during, and after the stimulation and during and after the walking therapy. Investigators will also ask about how the stimulation made participants feel.

The group in the trial

  • taVNS applicationTreatment being tested

    This is a single arm study with two Phases. In Phase 1 taVNS will be applied bilaterally for a brief period while the individual is in inpatient rehabilitation In Phase 2 taVNS will be applied for a brief period immediately before each mobility therapy session while the period is in inpatient rehabilitation. The mobility therapy sessions are routine care. Frequency and intensity of these sessions are determined by the therapists. All individuals must complete Phase 1 before starting Phase 2. Not all individuals who complete Phase 1 will be eligible for Phase 2. Please see eligibility criteria for more details.

    Treatment: Transauricular vagus nerve stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pilot Investigation of Transauricular Vagal Nerve Stimulation Safety and Feasibility in Acute Incomplete Spinal Cord Injury Rehabilitation
Plain-language title
Ear nerve stimulation for people recently injured with spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07562113, who can take part
Record updated
5 August 2026